Jose A G Agundez
Overview
Explore the profile of Jose A G Agundez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
210
Citations
3281
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Agundez J, Garcia-Martin E
Front Pharmacol
. 2025 Jan;
15():1540478.
PMID: 39830351
No abstract available.
2.
Agundez J, Macias Y, Alonso-Navarro H, Garcia-Martin E, Alvarez I, Pastor P, et al.
Int J Mol Sci
. 2025 Jan;
25(24.
PMID: 39769168
Many clinical, neuroimaging, neuropathological, epidemiological, and genetic data suggest a relationship between essential tremor (ET) and Parkinson's disease (PD). Several hypothesis-based gene association studies attempted to find a genetic association...
3.
Alonso-Navarro H, Garcia-Martin E, Agundez J, Jimenez-Jimenez F
Expert Rev Neurother
. 2024 Dec;
25(1):43-56.
PMID: 39648495
Introduction: The main treatment options for essential tremor (ET), which is probably one of the most common movement disorders, have been propranolol and primidone, for many years. This review aims...
4.
Jimenez-Jimenez F, Alonso-Navarro H, Salgado-Camara P, Garcia-Martin E, Agundez J
Biomolecules
. 2024 Oct;
14(10).
PMID: 39456199
Several studies have proposed a potential role for oxidative stress in the development of multiple sclerosis (MS). For this reason, it seems tentative to think that treatment with antioxidant substances...
5.
Duarte J, Thomas C, Lee C, Huddart R, Agundez J, Baye J, et al.
Clin Pharmacol Ther
. 2024 Jul;
116(4):939-947.
PMID: 38951961
Beta-blockers are widely used medications for a variety of indications, including heart failure, myocardial infarction, cardiac arrhythmias, and hypertension. Genetic variability in pharmacokinetic (e.g., CYP2D6) and pharmacodynamic (e.g., ADRB1, ADRB2,...
6.
Jimenez-Jimenez F, Alonso-Navarro H, Salgado-Camara P, Garcia-Martin E, Agundez J
Int J Mol Sci
. 2024 Jun;
25(12).
PMID: 38927996
The pathogenesis of multiple sclerosis (MS) is not completely understood, but genetic factors, autoimmunity, inflammation, demyelination, and neurodegeneration seem to play a significant role. Data from analyses of central nervous...
7.
Blanca-Lopez N, Agundez J, Fernandez J, Garcia-Martin E, Blanca M
Int Arch Allergy Immunol
. 2024 Jun;
185(10):953-963.
PMID: 38830344
Background: Ibuprofen, a non-steroidal anti-inflammatory drug (NSAID), is the most frequent medication to be involved in hypersensitivity drug reactions (HDRs). Other analgesic/anti-inflammatory drugs in the arylpropionic group are also relevant,...
8.
Jimenez-Jimenez F, Alonso-Navarro H, Garcia-Martin E, Espada-Rubio S, Agundez J
Mol Neurobiol
. 2024 Mar;
61(10):8344-8360.
PMID: 38499906
The pathogenesis of migraine is not completely understood, but inflammation and oxidative stress seem to be involved, according to data from an experimental model of the disease. This narrative review...
9.
Abad-Santos F, Alino S, Borobia A, Garcia-Martin E, Gasso P, Maronas O, et al.
Pharmacol Res
. 2024 Jan;
200:107061.
PMID: 38199278
The development of Pharmacogenetics and Pharmacogenomics in Western Europe is highly relevant in the worldwide scenario. Despite the usually low institutional support, many research groups, composed of basic and clinical...
10.
Turner A, Nofziger C, Ramey B, Ly R, Bousman C, Agundez J, et al.
Clin Pharmacol Ther
. 2023 Sep;
114(6):1220-1237.
PMID: 37669183
The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the highly polymorphic human CYP2D6 gene locus and a comprehensive summary of structural variation. CYP2D6 contributes to the metabolism of numerous drugs...